401 related articles for article (PubMed ID: 32873407)
1. Cancer Nanomedicines in an Evolving Oncology Landscape.
Guo P; Huang J; Moses MA
Trends Pharmacol Sci; 2020 Oct; 41(10):730-742. PubMed ID: 32873407
[TBL] [Abstract][Full Text] [Related]
2. Cancer Nanomedicine: Lessons for Immuno-Oncology.
Sengupta S
Trends Cancer; 2017 Aug; 3(8):551-560. PubMed ID: 28780932
[TBL] [Abstract][Full Text] [Related]
3. Emerging nanomedicines for anti-stromal therapy against desmoplastic tumors.
Han X; Xu Y; Geranpayehvaghei M; Anderson GJ; Li Y; Nie G
Biomaterials; 2020 Feb; 232():119745. PubMed ID: 31918228
[TBL] [Abstract][Full Text] [Related]
4. Combining Nanomedicine and Immunotherapy.
Shi Y; Lammers T
Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
[TBL] [Abstract][Full Text] [Related]
5. Polyprodrug Nanomedicines: An Emerging Paradigm for Cancer Therapy.
Yang K; Yang Z; Yu G; Nie Z; Wang R; Chen X
Adv Mater; 2022 Feb; 34(6):e2107434. PubMed ID: 34693571
[TBL] [Abstract][Full Text] [Related]
6. Development of next generation nanomedicine-based approaches for the treatment of cancer: we've barely scratched the surface.
Tracey SR; Smyth P; Barelle CJ; Scott CJ
Biochem Soc Trans; 2021 Nov; 49(5):2253-2269. PubMed ID: 34709394
[TBL] [Abstract][Full Text] [Related]
7. Bridging Bio-Nano Science and Cancer Nanomedicine.
Björnmalm M; Thurecht KJ; Michael M; Scott AM; Caruso F
ACS Nano; 2017 Oct; 11(10):9594-9613. PubMed ID: 28926225
[TBL] [Abstract][Full Text] [Related]
8. Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy.
Gao J; Wang WQ; Pei Q; Lord MS; Yu HJ
Acta Pharmacol Sin; 2020 Jul; 41(7):986-994. PubMed ID: 32317755
[TBL] [Abstract][Full Text] [Related]
9. Current understandings and clinical translation of nanomedicines for breast cancer therapy.
Jiang Y; Jiang Z; Wang M; Ma L
Adv Drug Deliv Rev; 2022 Jan; 180():114034. PubMed ID: 34736986
[TBL] [Abstract][Full Text] [Related]
10. Next-Generation Polymeric Nanomedicines for Oncology: Perspectives and Future Directions.
Fletcher NL; Kempe K; Thurecht KJ
Macromol Rapid Commun; 2020 Sep; 41(18):e2000319. PubMed ID: 32767396
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in dual- and multi-responsive nanomedicines for precision cancer therapy.
Zhang Y; Li J; Pu K
Biomaterials; 2022 Dec; 291():121906. PubMed ID: 36395660
[TBL] [Abstract][Full Text] [Related]
12. Nanomedicines for cancer therapy: current status, challenges and future prospects.
Bor G; Mat Azmi ID; Yaghmur A
Ther Deliv; 2019 Feb; 10(2):113-132. PubMed ID: 30678550
[TBL] [Abstract][Full Text] [Related]
13. Carrier-Free Nanomedicine for Cancer Immunotherapy.
Fu Y; Bian X; Li P; Huang Y; Li C
J Biomed Nanotechnol; 2022 Apr; 18(4):939-956. PubMed ID: 35854464
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional Cargo-Free Nanomedicine for Cancer Therapy.
Wang Y; Yang P; Zhao X; Gao D; Sun N; Tian Z; Ma T; Yang Z
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30274177
[TBL] [Abstract][Full Text] [Related]
15. Survey of Clinical Translation of Cancer Nanomedicines-Lessons Learned from Successes and Failures.
He H; Liu L; Morin EE; Liu M; Schwendeman A
Acc Chem Res; 2019 Sep; 52(9):2445-2461. PubMed ID: 31424909
[TBL] [Abstract][Full Text] [Related]
16. Antibody-Incorporated Nanomedicines for Cancer Therapy.
Wu SY; Wu FG; Chen X
Adv Mater; 2022 Jun; 34(24):e2109210. PubMed ID: 35142395
[TBL] [Abstract][Full Text] [Related]
17. Cancer nanomedicine meets immunotherapy: opportunities and challenges.
Sun Q; Bai X; Sofias AM; van der Meel R; Ruiz-Hernandez E; Storm G; Hennink WE; De Geest B; Kiessling F; Yu HJ; Lammers T; Shi Y
Acta Pharmacol Sin; 2020 Jul; 41(7):954-958. PubMed ID: 32555445
[TBL] [Abstract][Full Text] [Related]
18. Tumor-Targeted Nanomedicine for Immunotherapy.
Cabral H; Kinoh H; Kataoka K
Acc Chem Res; 2020 Dec; 53(12):2765-2776. PubMed ID: 33161717
[TBL] [Abstract][Full Text] [Related]
19. Enhancing cancer immunotherapy with nanomedicine.
Irvine DJ; Dane EL
Nat Rev Immunol; 2020 May; 20(5):321-334. PubMed ID: 32005979
[TBL] [Abstract][Full Text] [Related]
20. Recent advances and clinical translation of liposomal delivery systems in cancer therapy.
Chen J; Hu S; Sun M; Shi J; Zhang H; Yu H; Yang Z
Eur J Pharm Sci; 2024 Feb; 193():106688. PubMed ID: 38171420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]